Rana R. McKay

Research interests

Publications

• Prostate Cancer, Version 3.2024

  Journal of the National Comprehensive Cancer Network · 2024 · https://doi.org/10.6004/jnccn.2024.0019

• Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)

  European Urology · 2024 · https://doi.org/10.1016/j.eururo.2024.09.017

• Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer

  Journal of Clinical Oncology · 2023 · https://doi.org/10.1200/jco.22.02887

• Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology

  Journal of the National Comprehensive Cancer Network · 2023 · https://doi.org/10.6004/jnccn.2023.0050

• NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.

  PubMed · 2022 · https://doi.org/10.6004/jnccn.2022.0063

• Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer

  Journal of Clinical Oncology · 2022 · https://doi.org/10.1200/jco.22.01643

• Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

  Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.02.024

• NCCN Guidelines Insights: Prostate Cancer, Version 1.2021

  Journal of the National Comprehensive Cancer Network · 2021 · https://doi.org/10.6004/jnccn.2021.0008

• RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach

  Nature · 2020 · https://doi.org/10.1038/s41586-020-2095-1

• Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

  The Lancet · 2020 · https://doi.org/10.1016/s0140-6736(20)31187-9

• Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study

  The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(18)30907-0

• Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone

  Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.18.01777

• Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations

  Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2016.66.7311

• Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway

  Cancer · 2014 · https://doi.org/10.1002/cncr.28972

• Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy

  European Urology · 2013 · https://doi.org/10.1016/j.eururo.2013.08.012

• NCCN Task Force Report: Bone Health in Cancer Care

  Journal of the National Comprehensive Cancer Network · 2013 · https://doi.org/10.6004/jnccn.2013.0215

Current projects

No projects listed.